Vitamin D and Alzheimer Risk: What a New Midlife Study Found

A study published in April 2026 in Neurology found that people with higher vitamin D levels in early midlife had less tau protein buildup in the brain roughly 16 years later. Tau accumulation is one of the core biological markers of Alzheimer’s disease. For residents of Maine and New Hampshire, where sun exposure drops sharply for five or six months of the year, that finding carries some weight.

What the Study Actually Measured

Researchers followed 793 adults from the Framingham Heart Study, all dementia-free at the start. Their average age at enrollment was 39. A single blood draw measured each participant’s serum 25-hydroxyvitamin D level in early midlife. Then, about 16 years later, participants underwent brain PET scans to assess tau and amyloid deposits.

People with vitamin D levels at or above 30 ng/mL showed lower tau deposition on imaging compared to those with lower levels. The relationship held up after the researchers adjusted for factors including sex, body mass index, physical activity, and APOE4 carrier status, a genetic variant that raises Alzheimer’s risk. No link was found between vitamin D and amyloid, the other protein associated with Alzheimer’s.

The lead author, Dr. Martin Mulligan of the University of Galway, described the results as promising but cautious: the study shows a relationship, not proof of cause and effect.

Why This Matters in Northern New England

Maine and New Hampshire sit between 43 and 45 degrees north latitude. At that distance from the equator, the angle of sunlight from October through April is too shallow for skin to produce meaningful vitamin D. That’s not an opinion; it’s basic photobiology, and the seasonal cutoffs for vitamin D synthesis at this latitude are more restrictive than most people expect. Most people at this latitude who don’t take a supplement and don’t eat fatty fish regularly will see their vitamin D levels fall during winter months.

Deficiency here isn’t unusual. It’s the norm for a good portion of the year. The same extended darkness that drives seasonal mood disruption across northern New England also limits the skin’s ability to make vitamin D for months at a stretch.

The study doesn’t say that living in a northern state causes Alzheimer’s, and it doesn’t recommend any particular supplement dose. What it adds is a data point: vitamin D status in your 30s may matter for the brain down the road, not just for bone health today.

What This Study Can’t Tell Us

Observational studies like this one are good at spotting patterns. They’re not built to prove that fixing a pattern fixes the outcome. Vitamin D levels in your blood reflect a mix of diet, sun habits, body composition, and genetics. It’s possible that people who maintain higher levels are also doing other things that protect the brain, and the researchers can’t fully separate those threads.

Randomized controlled trials testing whether vitamin D supplements actually reduce tau or prevent dementia are underway but haven’t reported conclusive results yet. Until they do, this study is a signal worth paying attention to, not a prescription. For residents already considering supplementation, understanding how vitamin D3 dose and form affect absorption is a reasonable place to start.

For the broader context on vitamin D this far north, see our complete guide to vitamin D in Maine.

Sources

• Mulligan MD, Scott MR, Yang Q, et al. Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology. 2026. doi:10.1212/WN9.0000000000000057
• American Academy of Neurology. Press release: Is vitamin D associated with lower levels of Alzheimer’s biomarker? Published April 2026. aan.com
• ScienceDaily. Your vitamin D levels in midlife could shape your brain decades later. April 7, 2026. sciencedaily.com

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.